Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 25295622)

Published in Gynecol Endocrinol on October 08, 2014

Authors

Daniel H Kort1, Alessandra Kostolias, Chantae Sullivan, Roger A Lobo

Author Affiliations

1: Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons , New York, NY , USA.

Articles by these authors

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med (2003) 2.63

Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab (2010) 2.27

Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause (2005) 1.61

A 20-year follow-up of young women with polycystic ovary syndrome. Obstet Gynecol (2012) 0.93

Best practices of ASRM and ESHRE: a journey through reproductive medicine. Fertil Steril (2012) 0.87

Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women. Menopause (2010) 0.87

Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial). Am J Cardiol (2008) 0.86

Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT). Atherosclerosis (2005) 0.84

Ovarian adipocytokines are associated with early in vitro human embryo development independent of the action of ovarian insulin. J Assist Reprod Genet (2012) 0.81

Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease. Circulation (2003) 0.80

What is the effect of estrogen on blood pressure after menopause? Menopause (2006) 0.75

Comparative effectiveness of robotically assisted compared with laparoscopic adnexal surgery for benign gynecologic disease. Obstet Gynecol (2014) 0.75

Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications. Int J Gynecol Cancer (2013) 0.75

Words of thanks to Dr. Alan H. DeCherney. Fertil Steril (2011) 0.75